5 results on '"Aimanianda, Vishukumar"'
Search Results
2. Complement-Mediated Differential Immune Response of Human Macrophages to Sporothrix Species Through Interaction With Their Cell Wall Peptidorhamnomannans
- Author
-
Neves, Gabriela W. P., primary, Wong, Sarah Sze Wah, additional, Aimanianda, Vishukumar, additional, Simenel, Catherine, additional, Guijarro, J. Iñaki, additional, Walls, Catriona, additional, Willment, Janet A., additional, Gow, Neil A. R., additional, Munro, Carol A., additional, Brown, Gordon D., additional, and Lopes-Bezerra, Leila M., additional
- Published
- 2021
- Full Text
- View/download PDF
3. Proteomic Analysis of Humoral Immune Components in Bronchoalveolar Lavage of Patients Infected or Colonized by Aspergillus fumigatus
- Author
-
Dellière, Sarah, primary, Duchateau, Magalie, additional, Wong, Sarah Sze Wah, additional, Giai Gianetto, Quentin, additional, Guegan, Hélène, additional, Matondo, Mariette, additional, Gangneux, Jean-Pierre, additional, and Aimanianda, Vishukumar, additional
- Published
- 2021
- Full Text
- View/download PDF
4. Aspergillus fumigatus Infection in Humans With STAT3-Deficiency Is Associated With Defective Interferon-Gamma and Th17 Responses
- Author
-
Danion, François, primary, Aimanianda, Vishukumar, additional, Bayry, Jagadeesh, additional, Duréault, Amélie, additional, Wong, Sarah Sze Wah, additional, Bougnoux, Marie-Elisabeth, additional, Tcherakian, Colas, additional, Alyanakian, Marie-Alexandra, additional, Guegan, Hélène, additional, Puel, Anne, additional, Picard, Capucine, additional, Lortholary, Olivier, additional, Lanternier, Fanny, additional, and Latgé, Jean-Paul, additional
- Published
- 2020
- Full Text
- View/download PDF
5. Aspergillus fumigatus Infection in Humans With STAT3-Deficiency Is Associated With Defective Interferon-Gamma and Th17 Responses
- Author
-
François Danion, Vishukumar Aimanianda, Jagadeesh Bayry, Amélie Duréault, Sarah Sze Wah Wong, Marie-Elisabeth Bougnoux, Colas Tcherakian, Marie-Alexandra Alyanakian, Hélène Guegan, Anne Puel, Capucine Picard, Olivier Lortholary, Fanny Lanternier, Jean-Paul Latgé, Centre d'infectiologie Necker-Pasteur [CHU Necker], CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut Pasteur [Paris], Aspergillus, Institut Pasteur [Paris], Immuno-pathologie et immuno-intervention thérapeutique = Immunopathology and Therapeutic Immuno-intervention [CRC], Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université de Paris (UP)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université de Paris (UP), Unité de Parasitologie-Mycologie, Service de Microbiologie [Hôpital Necker-Enfants-Malades, Paris], Assistance Publique - Hôpitaux de Paris, Biologie et Pathogénicité fongiques - Fungal Biology and Pathogenicity (BPF), Institut Pasteur [Paris]-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Service de pneumologie [Hôpital Foch], Hôpital Foch [Suresnes], Immunologie biologique [CHU Necker], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Service de Parasitologie-Mycologie [Rennes], Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-CHU Pontchaillou [Rennes], Rockefeller University [New York], Imagine - Institut des maladies génétiques (IHU) (Imagine - U1163), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Centre de Référence Déficits Immunitaires Héréditaires (CEREDIH), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université de Paris (UP), Centre National de Référence Mycoses Invasives et Antifongiques - National Reference Center Invasive Mycoses & Antifungals (CNRMA), Mycologie moléculaire - Molecular Mycology, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), This work was supported by the French national reference center for Primary Immunodeficiencies [CEREDIH, Hôpital Necker-Enfants malades, Assistance Publique-Hôpitaux (AP-HP) de Paris, Paris, France]. VA was supported by Franco-Indian CEFIPRA (project No. 5403-1) and ANR-DFG AfuINT grants. Imagine Institute work was supported by the Agence Nationale de la Recherche – Investissements d'Avenir program (ANR-10-IAHU-01)., French national reference center for Primary Immunodeficiencies [CEREDIH, Hopital Necker-Enfants malades, Assistance Publique-Hopitaux (APHP) de Paris, Paris, France]Franco-Indian CEFIPRA5403-1, ANR-10-IAHU-0001,Imagine,Institut Hospitalo-Universitaire Imagine(2010), Institut Pasteur [Paris] (IP)-CHU Necker - Enfants Malades [AP-HP], Institut Pasteur [Paris] (IP), École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité)-École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité), Institut Pasteur [Paris] (IP)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Université de Rennes (UR)-Hôpital Pontchaillou-CHU Pontchaillou [Rennes], Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Université Paris Cité (UPCité), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Aimanianda, Vishukumar, Instituts Hospitalo-Universitaires - Institut Hospitalo-Universitaire Imagine - - Imagine2010 - ANR-10-IAHU-0001 - IAHU - VALID, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité)-École pratique des hautes études (EPHE), Immunopathologie et immunointervention thérapeutique (CRC - Inserm U1138), École pratique des hautes études (EPHE)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-École pratique des hautes études (EPHE)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Biologie et Pathogénicité fongiques, Service de pneumologie [Hôpital Foch, Suresnes], Service d'immuno-hématologie pédiatrique [CHU Necker], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Necker - Enfants Malades [AP-HP], Génétique Humaine des Maladies Infectieuses (Equipe Inserm U1163), Imagine - Institut des maladies génétiques (IMAGINE - U1163), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), and ANR-10-IAHU-0001/10-IAHU-0001,Imagine,Imagine(2010)
- Subjects
lcsh:Immunologic diseases. Allergy ,autosomal dominant hyper-IgE syndrome (AD-HIES) ,IgG ,[SDV]Life Sciences [q-bio] ,Immunology ,innate/adaptive immunity ,Immunoglobulin E ,Aspergillosis ,Peripheral blood mononuclear cell ,Aspergillus fumigatus ,03 medical and health sciences ,Immune system ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,medicine ,Immunology and Allergy ,signal transducer and activator of transcription 3 (STAT3) ,Interferon gamma ,aspergillosis ,030304 developmental biology ,Original Research ,0303 health sciences ,Aspergillus ,[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,biology ,030306 microbiology ,business.industry ,Acquired immune system ,biology.organism_classification ,medicine.disease ,3. Good health ,[SDV] Life Sciences [q-bio] ,[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,biology.protein ,IgE ,lcsh:RC581-607 ,business ,loss-of-function mutation ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,medicine.drug - Abstract
In humans, loss-of-function mutation in the Signal Transducer and Activator of Transcription 3 (STAT3) gene is frequently associated with susceptibility to bacterial as well as fungal infections including aspergillosis, although its pathogenesis remains largely unknown. In the present study, we investigated the immune responses obtained after stimulation with Aspergillus fumigatus in STAT3-deficient patients. A. fumigatus conidial killing efficiencies of both monocytes and neutrophils isolated from whole blood samples of STAT3-deficient patients were not different compared to those of healthy controls. After stimulation with A. fumigatus conidia, lower concentrations of adaptive cytokines (IFN-γ, IL-17 and IL-22) were secreted by peripheral blood mononuclear cells from STAT3-deficient patients compared to those from healthy controls. Moreover, the frequency of IFN-γ and IL-17 producing CD4+ T cells was lower in STAT3-deficient patients vs. healthy controls. Among the STAT3-deficient patients, those with aspergillosis showed further lower secretion of IFN-γ upon stimulation of their PBMCs with A. fumigatus conidia compared to the patients without aspergillosis. Together, our study indicated that STAT3-deficiency leads to a defective adaptive immune response against A. fumigatus infection, particularly with a lower IFN-γ and IL-17 responses in those with aspergillosis, suggesting potential therapeutic benefit of recombinant IFN-γ in STAT3-deficient patients with aspergillosis.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.